Schrödinger Announces Collaboration with AstraZeneca to Deploy Advanced Computing Technology for Drug Discovery Read more
ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform Read more
Tagrisso approved in China as a 1st-line treatment for EGFR-mutated non-small cell lung cancer Read more